TGF-β codon 25 polymorphism and the risk of graft-versus-host disease after allogenic hematopoietic stem cell transplantation

Iranian Journal of Allergy, Asthma and Immunology

Volumn 9, Issue 1, 2010, Pages 1-6

  Rashidi Nezhad, Ali ^a   Azimi, Cyrus ^a   Alimoghaddam, Kamran ^b   Ghavamzadeh, Ardeshir ^b   Hossein Nezhad, Arash ^b   Izadi, Pantea ^a   Sobhani, Maryam ^a   Noori Daloii, Ali Reza ^a   Noori Daloii, Mohammad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute GVHD; BMT; Cytokine gene polymorphism; SNP; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CODON; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; POLYMERASE CHAIN REACTION; RECIPIENT; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; CODON; FEMALE; GENE FREQUENCY; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; POLYMORPHISM, GENETIC; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 77954357233     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. MacMillan ML, Radloff GA, DeFor TE, Weisdorf DJ, Davies SM. Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation. Br J Hematol 2003; 121(4):597-604. (Pubitemid 36645381)
2. Rocha V, Franco RF, Porcher R, Bittencourt H, Silva WA JR, Latouche A, et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 100(12):3908-18.
3. Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Hematol 2004; 127(5):479-90.
4. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94(11):3941-6.
5. Hattori H, Matsuzaki A, Suminoe A, Ihara K, Nagatoshi Y, Sakata N, et al. Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation. Bone Marrow Transplant 2002; 30(10):665-71.
6. Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, et al. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogenic hematopoietic stem cell transplantation. Scand J Immunol 2007; 66(6):703-10.
7. Mullighan C, Heatley S, Doherty K, Szabo F, Grigg A, Hughes T, et al. Non-HLA immunogenetic polymorphisms and the risk of complications after allogenic hemopoietic stem-cell transplantation. Transplantation 2004; 77(4):587-96.
8. Middleton PG, Taylor PR, Jackson G, Proctor SJ, Dickinson AM. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 1998; 92(10):3943-8.
9. Banovic T, MacDonald KP, Morris ES, Rowe V, Kuns R, Don A, et al. TGF-beta in allogenic stem cell transplantation: friend or foe? Blood 2005; 106(6):2206-14.
10. Lympany PA, Avila JJ, Mullighan C, Marshall S, Welsh KI, du Bois RM. Rapid genotyping of transforming growth factor beta1 gene polymorphisms in a UK Caucasoid control population using the polymerase chain reaction and sequence-specific primers. Tissue Antigens 1998; 52(6):573-8.
11. Kim SJ, Glick A, Sporn MB, Roberts AB. Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem 1989; 264(1):402-8.
12. Noori-Daloii MR, Rashidi-Nezhad A, Izadi P, Hossein-Nezhad A, Sobhani M, Derakhshandeh-Peykar P, et al. Transforming growth factor-beta1 codon 10 polymorphism is associated with acute GVHD after allogenic BMT in Iranian population. Ann Transplant 2007; 12(4):5-10.
13. Nooridaloii MR, Sobhani M, Izadi P, Fotouhi A, Ali-Moghaddan K, Irvani M, et al. Study of relationship between IL-1Ra gene polymorphism and GVHD in HLA-identical sibling allogenic transplants. Arch Med Sci 2007; 3:52-6.
14. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18(4):295-304.
15. Holler E, Rogler G, Brenmoehl J, Hahn J, Greinix H, Dickinson AM, et al. The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation. Int J Immunogenet 2008; 35(4-5):381-4.
16. Gerbitz A, Hillemanns P, Schmid C, Wilke A, Jayaraman R, Kolb H J, et al. Influence of polymorphism within the heme oxygenase-I promoter on overall survival and transplantation-related mortality after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2008; 14(10):1180-9.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215.
18. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001; 98:1594-600.
19. Bogunia-Kubik K, Suchnicki K, Lange A. HLA-DR11 in addition to donor age, gender, and major blood group incompatibility influence the incidence of acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation. Transplant Proc 2003; 35(4):1556-8.
20. Khoshniat M, Ghavamzadeh A, Larijani B, Bahar B, Tabatabaei O. Effect on growth parameters of bone marrow transplantation with a chemotherapy-only conditioning regimen. Transplant Proc 2003; 35(8):3085-8.
21. Mohyeddin Bonab M, Alimoghaddam K, Vatandoust S, Forouzia F, Jahani M, Ghavamzadeh A. Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation? Transplant Proc 2004; 36(10):3190-93.
22. Ghavamzadeh A, Larijani B, Jahani M, Khoshniat M, Bahar B, Tabatabaei O. Thyroid, parathyroid, gonadal, and pancreatic beta-cell function after bone marrow transplantation with chemotherapy-only conditioning. Transplant Proc 2003; 35(8):3101-04.
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3):1215-18.
24. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 1999; 7(2):127-28.
25. Li Z, Habuchi T, Tsuchiya N, Wang L, Ohyama C, Sato K, et al. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10. Carcinogenesis 2004; 25(2):237-40.
26. Ambruzova Z, Mrazek F, Raida L, Faber E, Onderkova J, Kriegova E, et al. Association of IL-6 gene polymorphism with the outcome of allogeneic haematopoietic stem cell transplantation in Czech patients. Int J Immunogenet. 2008; 35(4-5):401-3.
27. Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, et al. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Scand J Immunol. 2007; 66(6):703-10.
28. Leffell MS, Vogelsang GB, Lucas DP, Delaney NL, Zachary AA. Association between TGF-beta expression and severe GVHD in allogenic bone marrow transplantation. Transplant Proc 2001; 33:485-6.
29. Amirzargar M, Yavangi M, Basiri A, Moghadam SH, Khosravi F, SolgiG, et al. Genetic association of interleukin-4, interleukin-10, and transforming growth factor-beta gene polymorphism with allograft function in renal transplant patients. Transplant Proc 2007; 39(4):954-57.